IP Library Granted Patent US 10,076,479
Granted Patent B1
US 10,076,479 · App. 15/974,106 · Granted Sep 18, 2018

Methods for treating skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,076,479
App. No.
15/974,106
Granted
Sep 18, 2018
Kind
B1
Abstract

Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.

Claims (29)

1. A method for diminishing dermatological signs of aging in human skin comprising, in any order, the steps of (1) topically applying to an area of the skin in need thereof, at least once daily, a first skin treatment composition comprising, in a physiologically compatible vehicle, an effective amount of an alpha-hydroxy acid or salt thereof for a first period of time comprising from 2 to 15 days; (2) topically applying to said skin, at least once daily, a second skin treatment composition that is different from said first skin treatment composition for a second period of time comprising from 2 to 15 days wherein said second skin treatment composition comprises a moisturizer; and (3) repeating steps (1) and (2) for a number of times sufficient to diminish said dermatological signs of skin aging.

2. The method according to claim 1 , wherein said alpha-hydroxy acid or salt thereof comprises glycolic acid or a salt thereof.

3. The method according to claim 1 , wherein said second skin treatment composition comprises a biological extract.

4. The method according to claim 3 , wherein said biological extract comprises an extract of a plant, yeast, or fungus.

5. The method according to claim 4 , wherein said extract of a plant, yeast, or fungus comprises an extract of Tiliacora triandra.

6. The method according to claim 1 , wherein said second skin treatment composition comprises niacinamide.

7. The method according to claim 1 , wherein said diminishing dermatological signs of aging is selected from the group consisting of:

(a) treatment, reduction, and/or prevention of fine lines and/or wrinkles;

(b) reduction of skin pore size;

(c) improvement in skin thickness, plumpness, and/or tautness;

(d) improvement in skin smoothness, suppleness and/or softness;

(e) improvement in skin tone, radiance, and/or clarity;

(f) improvement in procollagen, and/or collagen production;

(g) improvement in maintenance and remodeling of elastin;

(h) improvement in skin texture and/or promotion of retexturization;

(i) improvement in skin barrier repair and/or function;

(j) improvement in appearance of skin contours;

(k) restoration of skin luster and/or brightness;

(l) replenishment of essential nutrients and or constituents in the skin;

(m) improvement of skin appearance decreased by aging and/or menopause;

(n) improvement in skin moisturization;

(o) increase in skin elasticity and/or resiliency;

(p) treatment, reduction, and/or prevention of skin sagging;

(q) improvement in skin firmness;

(r) reduction of pigment spots and/or mottled skin; and

(s) improvement of optical properties of skin by light diffraction or reflection.

8. The method according to claim 1 , wherein said first period of time is 7 days, and said second period of time is 7 days.

9. The method according to claim 1 , wherein said first and second periods of time are consecutive such that one begins on the day following the last day of the other.

10. The method according to claim 1 , wherein said second skin treatment composition does not comprise an effective amount of an alpha-hydroxy acid.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2026
From: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
To: AVON PRODUCTS, INC.
Reel/Frame 074508/0281 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Apr 29, 2024
From: AVON PRODUCTS, INC.; MI HOLDINGS, INC.; AVON INTERNATIONAL OPERATIONS, INC.; AVON CAPITAL CORPORATION; AVON COSMETICS LIMITED; AVON BEAUTY LIMITED
To: NATURA &CO HOLDING S.A., AS SECURED PARTY; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA COSMÉTICOS S.A., AS A SECURED PARTY
Reel/Frame 067249/0491 →
SECURITY INTEREST Recorded Aug 11, 2023
From: AVON PRODUCTS, INC.
To: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
Reel/Frame 064566/0872 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2018
From: SANTHANAM, UMA; IDKOWIAK-BALDYS, JOLANTA; LEESON, DANIEL THORN; GONZALEZ, ANTHONY DAVID; ANDERSON, GLEN THOMAS
To: AVON PRODUCTS, INC.
Reel/Frame 045745/0267 →